These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 28485182

  • 21. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA, Georgakarakos EI, Antoniou SA, Georgiadis GS.
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [Abstract] [Full Text] [Related]

  • 22. Drug-Eluting Versus Bare-Metal Stent Implantation With or Without Cilostazol in the Treatment of the Superficial Femoral Artery.
    Miura T, Miyashita Y, Soga Y, Hozawa K, Doijiri T, Ikeda U, Kuwahara K, DEBATE in SFA Investigators.
    Circ Cardiovasc Interv; 2018 Aug; 11(8):e006564. PubMed ID: 30354784
    [Abstract] [Full Text] [Related]

  • 23. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.
    Zhou Y, Zhang Z, Lin S, Xiao J, Ai W, Wang J, Li Y, Li Q.
    J Endovasc Ther; 2020 Feb; 27(1):42-59. PubMed ID: 31948375
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Outcomes after Endovascular Stent Placement for Long-Segment Superficial Femoral Artery Lesions.
    Zamani N, Sharath SE, Browder RC, Barshes NR, Braun JD, Mills JL, Kougias P, Younes HK.
    Ann Vasc Surg; 2021 Feb; 71():298-307. PubMed ID: 32891746
    [Abstract] [Full Text] [Related]

  • 26. Endovascular Management of Femoropopliteal In-Stent Restenosis: A Systematic Review.
    Varela DL, Armstrong EJ.
    Cardiovasc Revasc Med; 2019 Oct; 20(10):915-925. PubMed ID: 30447898
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ, Beckman JA, Ansel G, Lyden SP, Schneider P, Mehta M, Dake M, Mullin CM, Jaff MR, VIVA Physicians, Inc.
    Catheter Cardiovasc Interv; 2017 Jun 01; 89(7):1250-1256. PubMed ID: 28303688
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Bare Metal Versus Paclitaxel-Eluting Stents for Long Femoropopliteal Lesions: Prospective Cohorts Comparison Using a Propensity Score-Matched Analysis.
    Vent PA, Kaladji A, Davaine JM, Guyomarch B, Chaillou P, Costargent A, Quillard T, Gouëffic Y.
    Ann Vasc Surg; 2017 Aug 01; 43():166-175. PubMed ID: 28300676
    [Abstract] [Full Text] [Related]

  • 31. Covered vs Uncovered Stents for Aortoiliac and Femoropopliteal Arterial Disease: A Systematic Review and Meta-analysis.
    Hajibandeh S, Hajibandeh S, Antoniou SA, Torella F, Antoniou GA.
    J Endovasc Ther; 2016 Jun 01; 23(3):442-52. PubMed ID: 27099281
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF, Mezzetto L, Macrì M, Criscenti P, Corvasce A, Poli R.
    Ann Vasc Surg; 2018 Feb 01; 47():179-187. PubMed ID: 28943491
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis.
    Varetto G, Gibello L, Boero M, Frola E, Peretti T, Spalla F, Verzini F, Rispoli P.
    J Cardiovasc Surg (Torino); 2019 Oct 01; 60(5):546-556. PubMed ID: 31527577
    [Abstract] [Full Text] [Related]

  • 36. Self-expanding nitinol stents of high versus low chronic outward force in de novo femoropopliteal occlusive arterial lesions (BIOFLEX-COF trial): study protocol for a randomized controlled trial.
    Wressnegger A, Kaider A, Funovics MA.
    Trials; 2017 Dec 14; 18(1):594. PubMed ID: 29237489
    [Abstract] [Full Text] [Related]

  • 37. Patients with failed femoropopliteal covered stents are more likely to present with acute limb ischemia than those with failed femoropopliteal bare metal stents.
    DeCarlo C, Boitano LT, Latz CA, Png CYM, Lee S, Dua A, Patel V, Schwartz SI.
    J Vasc Surg; 2021 Jul 14; 74(1):161-169.e1. PubMed ID: 33548436
    [Abstract] [Full Text] [Related]

  • 38. Combination therapy of heparin-bonded covered stent and bare-nitinol stent assessed by intravascular ultrasound.
    Katsuki T, Tomoi Y, Yamaji K, Soga Y, Imada K, Ito N, Hiramori S, Ando K.
    Heart Vessels; 2020 Nov 14; 35(11):1502-1509. PubMed ID: 32462463
    [Abstract] [Full Text] [Related]

  • 39. Midterm Patency After Femoropopliteal Interventions: A Comparison of Standard and Interwoven Nitinol Stents and Drug-Coated Balloons in a Single-Center, Propensity Score-Matched Analysis.
    Steiner S, Schmidt A, Bausback Y, Piorkowski M, Werner M, Yahiaoui-Doktor M, Banning-Eichenseer U, Scheinert D.
    J Endovasc Ther; 2016 Apr 14; 23(2):347-55. PubMed ID: 26848131
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.